Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0.0102 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.3229 | 0.3229 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0068 | 0.4604 | 0.4604 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0018 | 0.0102 | 0.5 |
Brugia malayi | RNA binding protein | 0.0068 | 0.4604 | 0.4604 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0.0102 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0068 | 0.4604 | 0.4604 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.4604 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0068 | 0.4604 | 0.4604 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0128 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0068 | 0.4604 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0068 | 0.4604 | 0.4604 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0222 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0018 | 0.0102 | 0.0222 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.4604 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.1734 | 0.1734 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0222 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0222 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.4604 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.4604 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0102 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.3229 | 0.3229 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0128 | 1 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.5 |
Brugia malayi | isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0102 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.3229 | 0.3229 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.4604 | 1 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0222 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1734 | 0.1734 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.5 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0222 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.1734 | 0.3767 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0102 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0018 | 0.0102 | 0.0222 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0018 | 0.0102 | 0.5 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0.0102 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0018 | 0.0102 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0068 | 0.4604 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0018 | 0.0102 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.3229 | 0.3229 |
Loa Loa (eye worm) | RNA binding protein | 0.0068 | 0.4604 | 0.4604 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0018 | 0.0102 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 4 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by micro-broth dilution method | ChEMBL. | 20598399 |
MIC (functional) | > 256 ug ml-1 | Antifungal activity against Candida albicans ATCC 76615 after 24 hrs by micro-broth dilution method | ChEMBL. | 20598399 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.